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Abstract 
This report describes the preparation and characterisation of a set of plasmid solutions, ERM-AD483a, ERM-AD483b and ERM-AD483c. The materials 
were produced in accordance with ISO Guide 34:2009. 
A DNA fragment specific for the identification of a porcine target was cloned into a pUC18 vector to construct the pIRMM-0104 plasmid. The nucleic 
acid sequence of the entire pIRMM-0104 plasmid was determined by dye terminator cycle sequencing. The plasmid was eluted in TElow buffer, and its 
concentration was measured by ultraviolet (UV) spectrophotometry. Afterwards, it was gravimetrically diluted to three different concentration levels. 
The plasmid copy number concentration of the three concentration levels were certified by digital and droplet digital quantitative polymerase chain 
reaction methods, dPCR and ddPCR respectively. In addition, between-unit homogeneity, as well as short-term and long-term stability was assessed in 
accordance with ISO Guide 35:2006. 
 
The materials are intended for the determination of a cut-off value to discriminate positive samples (containing the porcine target sequence) from 
negative samples by quantitative PCR as defined in the Standard Operating Procedure of the EU Reference Laboratory for Animal proteins (EURL-AP) 
according to Commission Regulation (EU) No 51/2013.  
 
As any certified reference material (CRM), ERM-AD483 can also be used for control charts or validation studies. The CRM is available as a set of three 
vials, each containing at least 1 mL of plasmid solution. The minimum amount of sample to be used is 4 µL.
   
  
 
 
 
 
CERTIFICATION REPORT 
 
A set of three plasmid DNA calibration solutions bearing 
a porcine-specific DNA fragment 
 
Certified Reference Materials: ERM®-AD483a, 
ERM®-AD483b, ERM®-AD483c 
 
 
J. Mátrai, P. Corbisier, S. Mazoua, A.M. Kortekaas, 
P.Y.J. Chung, S. Trapmann, H. Emons 
 
 
 
 
European Commission, Joint Research Centre 
Institute for Reference Materials and Measurements (IRMM) 
Geel, Belgium 
 
 
 
 
 
 
 
 Disclaimer 
 
Certain commercial equipment, instruments, and materials are identified in this paper to specify adequately the 
experimental procedure. In no case does such identification imply recommendation or endorsement by the 
European Commission, nor does it imply that the material or equipment is necessarily the best available for the 
purpose.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1 
Summary 
This report describes the preparation and characterisation of a set of plasmid solutions, 
ERM-AD483a, ERM-AD483b and ERM-AD483c. The materials were produced in 
accordance with ISO Guide 34:2009 [1]. 
 
A DNA fragment specific for the identification of a porcine target was cloned into a pUC18 
vector to construct the pIRMM-0104 plasmid. The nucleic acid sequence of the entire 
pIRMM-0104 plasmid was determined by dye terminator cycle sequencing. The plasmid was 
eluted in TElow buffer, and its concentration was measured by ultraviolet (UV) 
spectrophotometry. Afterwards, it was gravimetrically diluted to three different concentration 
levels. The plasmid copy number concentration of the three concentration levels were 
certified by digital and droplet digital quantitative polymerase chain reaction methods, dPCR 
and ddPCR respectively. In addition, between-unit homogeneity, as well as short-term and 
long-term stability was assessed in accordance with ISO Guide 35:2006 [2]. 
 
The materials are intended for the determination of a cut-off value to discriminate positive 
samples (containing the porcine target sequence) from negative samples by quantitative 
PCR as defined in the Standard Operating Procedure of the EU Reference Laboratory for 
Animal proteins (EURL-AP) according to Commission Regulation (EU) No 51/2013 [3, 4].  
 
As any certified reference material (CRM), ERM-AD483 can also be used for control charts 
or validation studies. The CRM is available as a set of three vials, each containing at least 
1 mL of plasmid solution. The minimum amount of sample to be used is 4 µL. 
 
The following certified values were assigned: 
 
 
Copy number concentration of the plasmid 
Certified Value [cp/µL] Uncertainty [cp/µL] 
ERM-AD483a1) 1262) 183) 
ERM-AD483b1) 342) 63) 
ERM-AD483c1) 92) 33) 
1) Copy number concentration of the double stranded plasmid as measured by a digital PCR (dPCR) and droplet 
digital PCR (ddPCR) methods amplifying a DNA fragment specific for porcine. 
2)
 The unweighted mean value of 7 independent determinations obtained by dPCR and by ddPCR. The value is 
traceable to the International System of units (SI). 
3) The uncertainty is an expanded uncertainty with a coverage factor k = 2 corresponding to a level of confidence 
of approximately 95 % estimated in accordance with ISO/IEC Guide 98-3, Guide to the Expression of Uncertainty 
in Measurement (GUM:1995), ISO, 2008 [5].  
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Glossary 
ANOVA  Analysis of variance 
b Slope in the equation of linear regression y = a + bx 
bp Base pair 
cp Number of copies 
BSE Bovine spongiform encephalopathy 
Cq Quantification threshold 
CI Confidence level 
CRM Certified reference material 
DNA Deoxyribonucleic acid 
EC European Commission 
EDTA Ethylenediaminetetraacetic acid 
EU European Union 
EURL-AP European Union Reference Laboratory for Animal Proteins in 
Feedingstuffs 
IRMM Institute for Reference Materials and Measurements of the JRC  
ISO International Organization for Standardization  
JRC Joint Research Centre 
k Coverage factor 
LB Luria-Broth medium 
M Molar mass 
MSbetween Mean of squares between-unit from an ANOVA 
MSwithin  Mean of squares within-unit from an ANOVA 
n Number of replicates per unit 
neff Number of effective replicates per unit, when per unit, the number of 
replicates is not the same. 
N Number of samples (=units) analysed 
n.a. Not applicable 
n.c. Not calculated 
PAPs Processed animal proteins 
PT Proficiency test  
qPCR Quantitative polymerase chain reaction 
dPCR
 
Digital qPCR 
ddPCR Digital droplet qPCR 
rel Index denoting relative figures (uncertainties etc.) 
RM Reference Material 
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RSD Relative standard deviation 
s Standard deviation 
sbb Between-unit standard deviation; an additional index "rel" is added when 
appropriate 
sbetween Standard deviation between groups as obtained from ANOVA; an 
additional index "rel" is added when appropriate 
smeas Standard deviation of measurement data; an additional index "rel" is 
added when appropriate 
swithin
 Standard deviation within groups as obtained from ANOVA; an additional 
index "rel" is added as appropriate 
swb Within-unit standard deviation 
T Temperature 
t Time 
TaqMan® Thermus aquaticus (Taq) DNA polymerase-based technology for 
fluorescent signal generation during in qPCR 
TElow Buffer containing TRIS, 0.01 mmol/L EDTA at pH 8.0 
TRIS Tris(hydroxymethyl)aminomethane 
u Standard uncertainty  
u*bb  Standard uncertainty related to a maximum between-unit inhomogeneity 
that could be hidden by method repeatability; an additional index "rel" is 
added as appropriate 
ubb Standard uncertainty related to a possible between-unit inhomogeneity; 
an additional index "rel" is added as appropriate 
usts Standard uncertainty of the short-term stability; an additional index "rel" 
is added as appropriate 
UV Ultraviolet 
V
 
Volume 
α Significance level 
νs,meas Degrees of freedom for the determination of the standard deviation smeas 
MSwithinν
 
Degrees of freedom of MSwithin 
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1. Introduction  
1.1 Background 
Since the outbreak of bovine spongiform encephalopathy (BSE), the use of processed 
animal proteins (PAPs) as feed ingredients for farmed animals and in aquacultures, is 
regulated within the European Union through several regulations (Regulation (EC) 999/2001, 
Regulation (EC) 1774/2002 and Regulation (EC) 1234/2003) [4, 6-8]. In 2001, all PAPs were 
banned from the feed, and only in 2013 was this ban lifted for non-ruminant PAPs to be used 
in aquacultures [9]. Moreover, Regulation (EC) 1774/2002 also bans intra-species recycling 
[7]. Following these regulations, methods for species-specific detection of PAPs in compound 
feeds is required.  
 
Regulation (EC) No 152/2009 has laid down the methods of sampling and analysis for the 
official control of feed [10]. The new Regulation (EU) No 51/2013 includes new PCR-based 
methods for the detection of animal constituents [4]. Using qPCR methods it is possible to 
identify PAP samples because of the presence of remaining species specific intact DNA 
fragments in the samples. DNA based analyses are particularly applicable to the detection of 
these DNA fragments since they can still be detected in processed feed samples in which the 
target protein concentration would be below the limit of detection of protein-based assays.  
 
A qPCR method for the detection of animal DNA in feed stuff has been validated by the EU 
Reference Laboratory (EURL-AP). Calibrants are needed to enable the implementation of 
this qPCR protocol used as an official control method for detecting the presence of PAPs in 
the feed. In particular, these calibrants are used to determine a threshold or cut-off value at 
which the PCR signal is considered to be negative thereby distinguishing positive from 
negative samples. The threshold value varies from one laboratory to another as qPCR 
quantification cycle (Cq) values are influenced by a large number of factors including the 
composition of the mastermix and the instrument used [11]. Therefore, each control 
laboratory must determine its own threshold value and verify this value on a regular basis. 
  
To fulfil this objective, certified reference materials (CRMs) are required. The first CRM of 
this kind was produced for the detection of PAPs of ruminant origin (ERM-AD482). In the 
scope of the current project, JRC-IRMM has produced ERM-AD483 for the detection of PAPs 
of porcine origin. This CRM for porcine detection is required not only because of the 
reauthorized use of porcine PAPs in aquacultures since 2013 [9], but also because of the 
expectation that in 2015, the ban on PAPs in feed will be further lifted and porcine PAPs will 
be allowed in poultry feed. 
 
1.2 Choice of the material 
ERM-AD483a, b and c are certified for their absolute DNA copy number concentration and 
allow control laboratories to determine their cut-off values for the porcine assay [3, 11] and to 
report their results in line with European Commission Regulation (EU) No 51/2013 [4]. The 
plasmid of ERM-AD483a, b and c contains a porcine specific target DNA fragment of 83 
base pairs that can be amplified using two specific primers. Both the target and the 
primers/probe sequences were designed and provided to IRMM by EURL-AP. The three 
calibrants are certified for their plasmid DNA copy number concentrations.  
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1.3 Design of the project 
EURL-AP provided the plasmid. At IRMM the plasmid DNA was purified and linearized. The 
plasmid DNA concentration of the stock solution was measured by UV spectrophotometry 
and the three solutions at nominal values of 128 cp/µL, 32 cp/µL and 8 cp/µL were prepared 
by gravimetric dilution of this stock solution. The material has then been processed and DNA 
sequencing, homogeneity, characterisation, freeze-thaw, short- and long-term stability 
studies have been carried out by dPCR and ddPCR.  
2. Participants 
2.1 Starting material provider 
European Union Reference Laboratory in the detection of animal proteins in feedingstuffs 
(EURL-AP), Gembloux, BE 
2.2 Project management and evaluation, processing, homogeneity and 
stability studies 
European Commission, Joint Research Centre, Institute for Reference Materials and 
Measurements (IRMM), Geel, BE  
2.3 Characterisation study 
 
2.3.1 Sequence identity of the plasmid: 
Baseclear BV, Leiden, NL  
Eurofins Madigenomix GmbH, Ebersberg, DE 
 
2.3.2 Copy number concentration: 
National Measurement Institute (NMI), Department of Innovation, Industry, Science and 
Research, Bioanalysis Group, West Lindfield, AU 
European Commission, Joint Research Centre Institute for Health and Consumer Protection, 
Ispra, IT 
National Institute of Biology, Ljubljana, SI 
TATAA Biocenter AB, Göteborg, SE 
LGC Limited, Molecular and Cell Biology Team, Teddington, UK 
Centre Wallon de Recherches Agronomiques (CRA-W), Gembloux, BE 
European Commission, Joint Research Centre, Institute for Reference Materials and 
Measurements (IRMM), Geel, BE  
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3. Material processing and process control 
3.1 Origin and purity of the starting material 
The pIRMM-0104 plasmid was received from the EURL-AP as a bacterial culture in Luria 
broth (LB) medium supplemented with glycerol. After plating it on LB Agar supplemented with 
ampicillin, a single colony was picked and cultured overnight in 5 mL LB medium 
supplemented with ampicillin. The plasmid was extracted from the bacterial culture using 
silica columns (Qiaquick Gel extraction kit, Qiagen, Venlo, NL) and resuspended in TE low 
buffer (1 mM Tris, 0.01 mM EDTA, pH 8).  
3.1.1    Plasmid size confirmation  
The size of the pIRMM-0104 plasmid was confirmed by restriction enzyme digestion followed 
by agarose gel electrophoresis.  
3.1.2    Purity of the plasmid extract 
In theory, three different types of contaminants may be present in the plasmid extract: a) 
plasmids used for the assembly of pIRMM-0104, b) nucleic acids originating from host 
bacterial cells and c) non-nucleic acid contaminants.  
During the cloning process, the bacterial cells could have been transfected with different 
populations of plasmids: the plasmid of interest, and one of the plasmids used for the 
assembly of pIRMM-0104. The synthetic plasmids used for the cloning (pUC18 and pCR 2.1) 
have the same origin of replication (oriV from ColE1 plasmid) which allows them to replicate 
independently from the host chromosome (E. coli). A bacterial cell, however, cannot replicate 
different plasmids with the same mechanism of replication. As a consequence, only one 
plasmid will remain present in a bacterial clone whilst the other plasmids will be lost during 
cell division [12]. To ensure that the plasmid production started from a single bacterial clone, 
and would therefore contain only one type of plasmid, an additional plating step was 
included. A single colony containing the pIRMM-0104 was plated on an LB plate 
supplemented with ampicillin (50 µg/mL) and from this plate one isolated colony was picked 
for processing. 
After enzymatic digestion with SmaI and purification with the Qiaquick® Gel extraction kit, the 
purified plasmid solution was analysed by gel electrophoresis. As there was no smear and/or 
RNA bands observed, and it was concluded that the plasmid preparation was not 
contaminated with large amounts of genomic DNA or RNA molecules from host bacterial 
cells, although, trace levels of either molecules cannot be detected by gel electrophoresis.  
The linearized plasmid was analysed by spectrophotometry to detect the presence of non-
nucleic acid contaminants e.g. proteins. The UV absorbance of the plasmid in solution was 
measured at 260 nm (A260) and 280 nm (A280), where pure nucleic acid samples are expected 
to have a theoretical A260/A280 ratio of approximately 1.8 [13]. The A260/A280 was measured as 
1.83, indicating a sufficient DNA purity of the solution. However, this value does not exclude 
the presence of traces of contaminating proteins or chemical residues from nucleic acid 
extraction. 
Contamination of the stock solution of plasmid pIRMM-0104 with traces of nucleic acids from 
the host bacterial cell proteins may affect the DNA mass concentration measured by 
spectrophotometry and fluorometry. This may lead to an overestimation of the copy number 
concentration of the plasmid in solution. Nevertheless, such trace levels of nucleic acids do 
not affect the dPCR measurements as the used primers and probes are highly specific for 
the targeted sequences within a dPCR and do not hybridise with other DNA fragments which 
could be present in the final plasmid preparation. Inconsistencies between the estimations of 
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the copy number concentration based on spectrophotometry and dPCR can, therefore, be 
used as an indication of the presence of contaminants in the plasmid solution. 
Based on DNA mass concentration, the copy number concentration of the plasmid solution 
was estimated, applying equation 1:  
plasmid
ADNA
M
Ncionconcentratnumbercopy ⋅=
                                          Equation 1 
cDNA DNA mass concentration [ng/µl] 
AN  Avogadro constant [cp/mol] 
plasmidM
 
molar mass of the pIRMM-0104 plasmid [ng/mol] 
Calculation of the molar mass of the linear pIRMM-0104 plasmid was based on the DNA 
sequence of the plasmid and the molar mass of each nucleotide monophosphate [14].  
Nanodrop spectrophotometry measured the plasmid mass concentration as 17.4 ng/µl which 
gave a calculated copy number concentration of 5.65 x 109 cp/µl.  
3.2 Processing  
The plasmid stock solution was diluted in 1 mmol/L TElow (TRIS, 0.01 mmol/L EDTA at pH 
8.0) containing 51 ng/µL salmon sperm genomic DNA (Oncerhynchus keta, Sigma Aldrich 
Cat. No.: D-1626) to reach the target concentration of 1280 cp/µL. From this intermediate 
solution, three independent dilutions were gravimetrically prepared to obtain 2 L of solution, 
each with the following indicative concentrations: 128 cp/µL, 32 cp/µL and 8 cp/µL.  
From each final solution, a volume of approximately 1.1 mL was dispensed into 1200 sterile 
Axygen pre-labelled low binding vials under sterile and cooled conditions. Once filled, all 
vials were manually closed and were stored at -20 °C. The sets of calibrants were then 
prepared by assembling one vial of each concentration level, with the same identity number, 
into a plastic box and are stored back at -20 °C. At no point after the initial freezing were the 
vials allowed to thaw. 
3.3 Process control 
The final plasmid concentration was verified by dPCR from Fluidigm as described in Annex 
A. The copy number concentration was also verified by droplet digital PCR (ddPCR) using a 
QX100 droplet digital PCR system from Bio-Rad as described in Annex B. The measured 
copy number concentrations were in close agreement with the dPCR measurements (data 
not shown). 
4. Homogeneity study 
A key requirement for any reference material aliquotted into units is the equivalence between 
those units ensuring that the certified values of the CRM are valid for all vials of the material, 
within the stated uncertainty. Hence, ISO Guide 34 requires RM producers to quantify the 
between-unit variation, covered by performing between-unit homogeneity studies.  
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4.1 Between-unit homogeneity  
The between unit homogeneity was evaluated for each concentration level of ERM-AD483. 
The measurements were performed under repeatability conditions on vials randomly taken 
from the entire batch and analysed in a randomised order.  
Ten vials were selected using a random stratified sampling scheme covering the whole batch 
for the between-unit homogeneity test. Each selected vial of each concentration level was 
analysed 5 times independently by dPCR. The measurements of the randomised replicates 
were performed on 15 digital arrays. The measurements were performed under repeatability 
conditions in a randomised manner which allowed the separation of a potential analytical 
trend from a possible trend in the filling sequence.  
The mean values and corresponding standard deviations for each vial of the dPCR 
homogeneity measurements are shown in Figure 1: 
 
 
Figure 1: The 3 copy number concentrations measured by dPCR for level a (filled diamond), 
b (open diamond) and c (triangle) batches. Each point represents the average of 5 
measurements. Error bars indicate the standard deviation at 95 % CI.  
 
Regression analyses were performed to evaluate potential trends in the analytical sequence. 
Analytical trend was detected for ERM-AD483a and ERM-AD483b at 95 % CI, no analytical 
trend was observed for ERM-AD483c. Correction for this bias can improve the sensitivity of 
the subsequent statistical analysis through a reduction in analytical variation without masking 
potential between-unit heterogeneities. The analytical trend was corrected using the following 
formula: 
Corrected result =  Measured result id×    Equation 2 
With ii xxd /1=     
id
 correction factor for plate i  
1x
 mean value measured for all vials on chip 1 
ix
 mean value measured for all vials on chip i (2 to 5) 
ERM-AD483a 
ERM-AD483b 
ERM-AD483c C
o
py
 
n
u
m
be
r 
co
n
ce
n
tr
at
io
n
 
[cp
/ µµ µµ
L]
 
Tubes 
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The corrected dataset was then tested for trends in the filling sequence, which were not 
observed at a 95 % CI. The corrected dataset was then assessed for consistency using 
Single Grubbs outlier tests at a CI of 99 % both on the individual results and the unit means. 
No outliers were detected. 
Between-unit inhomogeneity analysis was determined by analysis of variance (ANOVA), 
which can separate the between-unit variation (sbb) from the within-unit variation (swb). The 
latter is equivalent to the method repeatability if the individual samples are representative for 
the whole unit. Evaluation by ANOVA requires unit means and results for each unit, both 
following unimodal distributions with approximately the same standard deviations. 
Distribution of the unit means was tested using histograms and normal probability plots. 
Minor deviations from unimodality of the individual values do not significantly affect the 
estimate of between-unit standard deviations. The distribution of the individual results is 
unimodal and of the unit means is normal.  
It should be noted that sbb,rel and swb,rel are estimates of the true standard deviations and, 
therefore, subject to random fluctuations. Therefore, the mean squares between groups 
(MSbetween) can be smaller than the mean squares within groups (MSwithin), resulting in 
negative arguments under the square root used for the estimation of the between-unit 
variation in Equation 4, whereas the true variation cannot be lower than zero. In this case, 
the maximum inhomogeneity that could be hidden by method repeatability (u*bb) was 
calculated as shown in Equation 5 and as described by Linsinger et al. [15]. u*bb is 
comparable to the limit of detection of an analytical method, yielding the maximum 
inhomogeneity that might be undetected by the given study setup.  
Within unit standard deviation (swb,rel), between–unit standard deviation (sbb,rel) and method 
repeatability (u*bb,rel) were calculated as:  
y 
within
rel,wb
MS
s =  Equation 3 
y
n
MSMS
s
withinbetween
rel,bb
−
=  Equation 4 
y
νn
MS
u
MSwithin
within
*
rel,bb
4
2
=  Equation 5 
MSwithin mean square within a unit from an ANOVA  
MSbetween mean squares between-unit from an ANOVA 
y  mean of all results of the homogeneity study 
n mean number of replicates per unit 
MSwithinν  degrees of freedom of MSwithin  
 
The results of the evaluation of the within and between-unit variations are summarised in 
Table 1. The resulting values from the above equations were converted into relative 
uncertainties.  
Since the homogeneity study showed no outlying unit means or trends in the filling 
sequence, the between-unit standard deviation (sbb) can be used as the estimate of ubb. As 
u*bb sets the limits of the study to detect inhomogeneity, the larger value of sbb and u*bb is 
adopted as uncertainty contribution to account for potential inhomogeneity. 
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Table 1: Results of the between-unit homogeneity study, measured by dPCR  
Material 
n 
 
swb,rel 
[%]
 
sbb,rel 
[%]
 
u*bb,rel 
[%] 
ubb,rel 
[%] 
ERM-AD483a 5 9.60 4.84 2.03 4.84 
ERM-AD483b 5 11.72 5.53 2.48 5.53 
ERM-AD483c 5 30.04 n.a.
1
 6.35 6.35 
1)
 Cannot be calculated as MSbetween < MSwithin, n is the number of independent measurements. 
4.2 Within-unit homogeneity and minimum sample intake 
The within-unit homogeneity is closely correlated to the minimum sample intake. This 
correlation implies that individual aliquots of a material will not contain the same amount of 
analyte. The minimum sample intake is the minimum amount of sample that is representative 
for the whole unit and thus can be used in an analysis.  
Homogeneity and stability studies were performed using a 4 µL sample intake. Thus, the 
4 µL sample intake gives acceptable repeatability, demonstrating that the within-unit 
inhomogeneity does no longer contribute to analytical variation using this sample intake.  
5. Stability study 
Temperature, time and radiation are considered as the most relevant influences of the 
stability of a material. Hence, stability testing is necessary to establish the conditions for 
storage (long-term stability) as well as conditions for dispatch to the customers (short-term 
stability).  
Stability studies were carried out using an isochronous design [16] and under repeatability 
conditions which greatly improves the sensitivity of the stability tests. In this approach, 
samples were stored for specified length of time at different temperature conditions, 
whereupon they were moved to conditions where further degradation can be assumed to be 
negligible (reference conditions). At the end of the isochronous storage, the samples were 
analysed simultaneously under repeatability conditions. 
5.1 Short-term stability study 
For the short-term stability (STS) study, samples were stored at +4 °C and -20 °C for each of 
0, 1, 2 and 4 weeks whereupon they were moved to a reference temperature of -70 °C. 
Samples were stored at two testing temperatures for safety reasons. Stability at -20 °C is 
tested to check the optimal transportation conditions and stability at +4 °C is tested to check 
the impact of elevated temperatures during transportation. Four units per storage time were 
selected using a random stratified sampling scheme. Each unit was measured once by 
dPCR and in three replicates by ddPCR. In case of the ddPCR measurements, not all the 
replicate measurements could be accepted due to technical reasons. The basis of technical 
rejection of a ddPCR measurement data is the unsatisfactory droplet quality. A measurement 
was accepted unless the number of generated droplets was below a threshold or when the 
so-called rain droplet profile was observed. The measurements were performed under 
repeatability conditions and in a randomised sequence to be able to separate a potential 
analytical trend from a trend over storage time. 
The obtained data were evaluated for each temperature on the pooled dPCR and ddPCR 
data set. The results were screened for outliers using the single and double Grubbs tests at 
99 % CI. The results of the statistical evaluation of the short-term stability are summarised in 
Table 2. 
14 
 Table 2: Uncertainty contribution estimated for 1 week of transportation by dPCR and 
ddPCR at -20 ºC and +4 ºC 
Material 
Number of individual 
outlying results at 
99 % CI, dPCR and 
ddPCR 
Significance of the 
trend at 95 % CI,  
dPCR and ddPCR 
usts [%] 
dPCR and 
ddPCR at  
-20 °C 
usts [%] 
dPCR and 
ddPCR at  
+4 °C 
-20 ºC +4 ºC -20 ºC +4 ºC 
ERM-
AD483a none
 none no no 1.11 1.19 
ERM-
AD483b none none no no 1.06 1.37 
ERM-
AD483c none none no no 1.46 1.80 
 
No outliers were detected and none of the trends were statistically significant at 95 % CI 
neither at -20 °C nor at 4 °C and by none of the methods. Uncertainties were calculated at 
week 1, to cover the transportation time. Based on these data the material shall be shipped 
frozen on dry ice, however even at 4 °C it is stable enough. The short-term-stability profile 
obtained by both methods, i.e. dPCR and ddPCR are shown by Figure 2. 
 
 
Figure 2: Stability of ERM-AD483a (blue diamond), b (red square) and c (green triangle) 
over 4 weeks. The error bars indicate standard deviations at CI of 95 %. The data shown are 
pooled data obtained by dPCR and ddPCR. 
5.2 Long-term stability study 
The long-term stability (LTS), i.e. storage conditions evaluation of ERM-AD483a, b and c was 
performed by storing the samples at -20 °C for each of 0, 2, 4, 6 and 12 months. The 
reference temperature was set to -70 °C. Five units per storage time were selected using a 
random stratified sampling scheme. Each unit was measured once using ddPCR, with the 
different concentration levels measured on different plates and on different days. The 
measurements were performed under repeatability conditions and in a randomised order to 
separate a potential analytical trend from a trend over storage time. Not all the replicate 
measurements could be accepted due to technical reasons. The basis of technical rejection 
of a ddPCR measurement data is the unsatisfactory droplet quality. A measurement was 
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accepted unless the number of generated droplets was below a threshold or when the so-
called rain droplet profile was observed. The results were screened for outliers using the 
single and double Grubbs tests. No outliers were observed and none of the trends were 
statistically significant on a 99 % CI. The results of the statistical evaluation of the long-term 
stability are summarised in Table 3. 
 
Table 3: Uncertainty contribution estimated for 1 year storage by ddPCR at -20 °C 
Material Number of individual 
outlying results, at 99 % CI 
Significance of the 
trend at 95 % CI uLTS [%] 
ERM-AD483a none no 4.28 
ERM-AD483b none no 4.92 
ERM-AD483c none no 9.59 
 
The data were plotted against storage time (Figure 3) and regression lines of copy number 
concentration versus time were calculated. No significant regression was found (99 % CI). 
The uncertainty contribution of LTS was calculated at 12 months and the values are shown in 
Table 3. 
 
 
 
Figure 3: Changes in copy number of ERM-AD483a (blue diamond), b (red square) and c 
(green triangle), over 12 months. The solid red line indicates the certified values. The red 
dashed lines indicate the combined expanded uncertainty of the certified values. The error 
bars indicate standard deviations at CI of 95 %. The data shown are obtained by ddPCR. 
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5.3 Freeze-thaw study 
A typical sample intake in a qPCR test is 5 µL and therefore 15 µL of each of the three 
calibration solutions are needed to establish a calibration curve with 3 replicates per 
concentration level. Each vial contains at least 1000 µL solution, which can be used to 
construct a minimum of 65 calibration curves per set. As the recommended storage 
temperature for the CRM set is -20 °C, repeated use of the CRM will require repeated freeze-
thaw cycles. The effect of repeated freeze-thaw cycles was therefore investigated. 
A similar approach to the isochronous design was followed in this study. Vials from ERM-
AD483a, ERM-AD483b and ERM-AD483c were analysed. For each concentration, two vials 
were exposed to 0, 1, 2, 3, 4 and 5 freeze-thaw cycles and moved to the reference 
temperature (-20 °C) until analysis. 
Each vial was measured once with simplex real time dPCR as described in Annex A. The 
measurements were done under intermediate precision conditions.  
The copy number concentration data were plotted against the number of freeze-thaw cycles 
and regression line analyses were performed. The slope of the regression lines was then 
tested for statistical significance (losses or increases due to freezing and thawing). For the 
test vials of ERM-AD483b and ERM-AD483c, the slopes of the regression lines were not 
significantly different from zero (at 99 % CI). For the test vials of ERM-AD483a, the slope of 
the regression line was significantly different from zero (at 99 % CI), but measured values 
stayed within the combined expanded uncertainty boundaries (Figure 4). Based on these 
data, the CRMs should be aliquotted and none of the CRMs should be exposed to more than 
a total of 3 freeze-thaw cycles. 
 
 
Figure 4: Freeze-thaw stability of ERM-AD483a (blue diamond), b (red square) and c (green 
triangle) over five cycles. The solid red line indicates the certified values. The red dashed 
lines indicate the combined expanded uncertainty of the certified values. The averages were 
calculated over n = 2. The error bars indicate standard deviations at CI of 95 %. 
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6. Characterisation study 
Material characterisation is the process of determining the property value, i.e. the plasmid 
copy number concentration of the reference material. 
 
6.1 Characterisation of the pIRMM-0104 sequence 
The sequence of pIRMM-0104 was determined by dideoxy terminator sequencing (or Sanger 
sequencing) applying the primer walking method.  
 
6.1.1 Study set up  
The selection of two nucleic acids sequencing companies was based on criteria that 
comprised aspects of both technical competence and quality management aspects. Both 
companies were required to operate a quality system and to deliver documented evidence of 
its laboratory proficiency in the field dideoxy terminator sequencing. Holding a formal 
accreditation was not mandatory, but meeting the requirements of ISO/IEC 17025 was 
obligatory.  
Both companies have received a vial containing 30 µL of circular pIRMM-0104 plasmid 
dissolved in TElow buffer, which had been set aside during the processing. The companies 
were commissioned to perform double stranded sequencing of an entire circular plasmid by 
primer walking method. Sequences were generated using the BigDye® Terminator chemistry 
version 3.0 (ABI). The sequence reactions were analysed on an ABI3730 capillary 
sequencer.  
 
6.1.2 Results 
Each company provided a full sequence of the pIRMM-0104 plasmid. Comparison of both 
sequences showed that they were identical to each other and were identical to the theoretical 
sequence, except for one nucleotide at the position 2236. This is a cytosine, as sequenced 
by the two companies (Seq1 and Seq2) and thymine in the theoretical sequence (Seq3), as 
shown by Annex C. Since Seq3 is an in silico sequence and because the mutation does not 
form part of the amplified sequence, which is indicated by yellow for the primer and cyan for 
the probe binding sites, it is, therefore, irrelevant. One of the companies also delivered the 
sequence quality values. The highest calculated cumulative error rate for the entire plasmid 
was found to be marginal: 1/1.4139 x109.  
6.2 Characterisation study for the copy number concentration of the 
plasmid 
The material characterisation was based on an interlaboratory comparison study performed 
by expert laboratories. dPCR and ddPCR measurements determined the certified value for 
the three different copy number concentrations of the plasmid. The participants used the 
BioMark system (Fluidigm) with the 12.765 digital arrays to perform the dPCR measurements 
and the QX100 system to perform the ddPCR measurements. This study design results in 
the randomisation of laboratory bias, thereby reducing the combined uncertainty. 
6.2.1 Study set up 
Seven laboratories were selected based on criteria that comprised aspects of both technical 
competence and quality management. Each participant was required to operate a quality 
system and to deliver documented evidence of its laboratory proficiency in the field of digital 
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PCR measurements. Holding a formal accreditation was not mandatory, but meeting the 
requirements of ISO/IEC 17025 was obligatory.  
dPCR measurements were performed by all the seven laboratories. Four out of the seven 
laboratories also performed ddPCR measurements. Each laboratory received two vials of 
each plasmid concentration of ERM-AD483 and was commissioned to provide two sets of 
results, one set per vial. Vials were selected using a random stratified sampling scheme 
covering the whole batch. None of the samples was diluted prior to the measurements. Each 
vial was analysed on five panels of one digital array. Each of the two vials was measured on 
different days and on different digital arrays or plates to ensure intermediate precision 
conditions were met. The PCR conditions for the characterisation study are shown in 
Annex A. 
6.2.2 Results 
The characterisation study resulted in seven independent dPCR and ddPCR pooled 
measurement results per CRM. The acquired data were first checked for compliance with the 
requested analysis protocol and their validity based on technical reasons. The following 
criteria were considered during the evaluation:  
• compliance with the analysis protocol: sample preparations and measurements 
performed on 6 different days 
• correctness of the reaction mix steps: all dilutions steps should have been prepared 
gravimetrically, and their masses were recorded  
• a visual check to ascertain that no air bubble was present in the panels  
• each independent set of dPCR measurement result should be based on the results of 
5 panels  
• ddPCR measurement results should be checked for droplet quantity and quality, i.e. 
the number of generated droplets should be more than 10000, and the droplets 
should not have a rain droplet profile 
Based on the above criteria, all the seven measurement sets were retained from the 
laboratories.  
The data were assessed for normality by using kurtosis/skewness tests and normal 
probability plots and were tested for outlying means using the Grubbs test and the Cochran 
test for outlying standard deviations (both at 99 % CI). The dataset means followed normal 
distributions and none of the data contained outlying means. The datasets were therefore 
consistent, and the means of independent measurement results is a good estimate of the 
true value.  
The uncertainty for the characterisation exercise was estimated as the relative standard 
uncertainty of the independent measurement results, i.e. with s the relative standard 
deviation of the technically valid independent measurements results and n the number of 
technically valid independent measurements. The results of these evaluations are shown in 
Table 4. 
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Table 4: Statistical evaluation for ERM-AD483, dPCR and ddPCR combined 
Copy number concentration of the plasmid 
CRM n Outliers Outliers Statistical parameters 
 
 Means Variances Normally  
distributed 
Mean 
[cp/µL] 
s 
[cp/µL] 
uchar 
[cp/µL] 
uchar,rel 
 [%] 
ERM-AD483a 7 none none yes 125.99 8.02 3.03 2.41 
ERM-AD483b 7 none none yes 33.78 3.55 1.34 3.98 
ERM-AD483c 7 none none yes 8.53 1.29 0.49 5.69 
Legends: n number of technically valid independent datasets, s standard deviation, uchar uncertainty related to the 
characterisation study and uchar, rel is the relative uncertainty related to the characterisation study 
 
7. Value assignment 
Certified values were assigned. Certified values are values that fulfil the highest standards of 
accuracy. Procedures at IRMM require pooling of not less than 6 datasets to assign certified 
values. Full uncertainty budgets following the 'Guide to the Expression of Uncertainty in 
Measurement' [5] were established. ERM-AD483 was certified for its copy number 
concentration by dPCR and ddPCR. 
7.1 Copy number concentration 
The unweighted mean of the accepted datasets, as shown in Table 5, was assigned as 
certified value for the copy number concentration of the plasmid. The value of the copy 
number concentration of the plasmid is traceable to SI. Traceability of the obtained results is 
based on the traceability of all relevant input factors. Instruments in individual laboratories 
were calibrated with tools ensuring traceability to the SI. Consistency in the intercomparison 
demonstrates that all relevant input factors were covered. As the assigned values are 
combinations of agreeing results individually traceable to the SI, the assigned quantity values 
themselves are also traceable to the SI. 
The assigned uncertainty consists of uncertainties relating to characterisation, uchar, to 
potential degradation during long-term storage, uLTS, to potential degradation during 
transportation, uSTS, and to potential between-unit heterogeneity, ubb. These different 
contributions were combined to estimate the relative expanded uncertainty of the certified 
value (UCRM, rel) with a coverage factor k as:  
 
2
rel bb,
2
rel LTS,
2
rel STS,
2
rel char,rel CRM, uu  uukU +++⋅=    Equation 6 
 
uchar,rel was estimated as described in Section 6 
uSTS,rel was estimated as described in Section 5 
uLTS,rel was estimated as described in Section 5 
ubb,rel was estimated as described in Section 4 
 
There were sufficient numbers of the degrees of freedom of the different uncertainty 
contributions, as measured by dPCR and ddPCR, and hence a coverage factor k of 2 was 
applied to calculate the expanded uncertainties.  
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The certified values and their uncertainties are summarised in Table 5. 
Table 5: Certified values and their uncertainties for the copy number concentration of ERM-
AD483 
CRM 
Copy number 
concentration 
of the plasmid 
[cp/µL] 
uchar, rel 
[%]
 
ubb, rel 
[%] 
uSTS, rel  
[%] 
uLTS, rel  
[%] 
UCRM, rel  
[%] 
UCRM  
[cp/µL] 
dPCR/ddPCR 
combined set 
dPCR/ddPCR 
combined set dPCR 
dPCR/ddPCR 
combined set ddPCR 
ERM-
AD483a 126 2.41 4.84 1.11 4.28 14 18 
ERM-
AD483b 34 3.98 5.53 1.06 4.92 17 6 
ERM-
AD483c 9 5.69 6.35 1.46 9.59 26 3 
 
8. Metrological traceability  
8.1 Metrological traceability  
8.1.1 Quantity value and identity of the measurand 
The DNA copy number concentration of ERM-AD483 is a method-defined measurand and 
has been obtained by dPCR and ddPCR using primers, probe and PCR conditions shown in 
Annex A, Table A1 and A2. Traceability of the results is based on the traceability of all 
relevant input factors. Instruments in individual laboratories were verified and calibrated with 
tools ensuring traceability to the SI. Consistency within each of the inter-laboratory 
comparisons demonstrates that all relevant input factors were covered. As the assigned 
values are combinations of agreeing results, individually traceable to the SI, the assigned 
quantity values themselves are also traceable to the SI. 
 
8.1.2 Sequence of the plasmid  
The plasmid DNA sequence and hence its identity was confirmed by two expert sequencing 
service companies using dye terminator cycle sequencing and applying the primer walking 
method on the entire plasmid. The participants used different methods for the sample 
preparation, as well as for the final determination of the sequence, demonstrating the 
absence of measurement bias. The identity of the measurand is therefore structurally defined 
and independent of the measurement method. 
 
In conclusion, the measurand is method-defined as the certified value was measured by 
dPCR and ddPCR. 
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9. Instructions for use 
9.1 Safety information 
The usual laboratory safety measures apply. 
9.2 Storage conditions 
The materials should be stored at -20 °C ± 5 °C prior to using. The plasmid containing 
solution should not be exposed to direct sunlight. 
It is advisable to close the vial with the original screw cap after use. The solutions can be 
used for several experiments assuming that major contaminations during the handling of 
opened vials are excluded. The material should however not undergo more than 3 freeze-
thaw cycles and therefore it is recommended to aliquot the solutions immediately at first use. 
Additionally, vortexing of the material is not recommended, and should be avoided. The 
material can also be stored at +4°C for a total maximum period of 1 month. 
Please note that the European Commission cannot be held responsible for changes which 
may occur happen during storage of the material at the customer's premises, especially of 
opened vials. 
 
9.3 Preparation and use of the material 
To prepare the plasmid solutions for use, the contents of the vials must be thawed 
completely and mixed gently by inverting the vial several times at ambient temperature. The 
vials should be opened and handled under a laminar flow cabinet to reduce the risk of 
contamination. The material is designed to be used to determine the cut-off values by the 
Standard Operating Procedures, edited by the EURL-AP [3] for the technical implementation 
of Regulation (EC) No 152/2009 [10]. 
The minimum sample intake is 4 µL.  
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11. Annex A: Description of the dPCR method 
The protocol described here was used in all the measurements at IRMM, as well as by all the 
laboratories participating in the characterisation study. The primers and probes are those 
provided by the EURL-AP for the qPCR protocol. Volumes of 4 µL of the undiluted ERM-
AD483a, ERM-AD483b, ERM-AD483c plasmid solutions were used in the dPCR assay. To 
analyse 12 replicate panels of the 12.765 Digital Array TM IFC's (Fluidigm), the DNA sample 
was mixed with the Pre-sample mix solution and 8 µL of this mixture was loaded per panel. 
The Pre-sample mix solution contained the primers and probes (2.25 µL each) for the 
porcine target at final concentrations outlined in Table A1 together with 20x GE sample 
loading reagent (6 µL) and Universal Mastermix (Diagenode, Liège, Belgium) (60 µL) as 
recommended by the EURL-AP. The PCR was performed according to the specifications 
mentioned in Table A2, which were then analysed with the Fluidigm Digital PCR Analysis V 
software, using the following settings: quality threshold of 0.4; linear baseline correction; 
automatic Cq threshold method; target Cq range between 20 and 50. 
Table A1: Primers and probes used to amplify the porcine target in a simplex dPCR reaction 
PCR 
target 
Primer/ probe Sequence Concentration 
in PCR reaction 
[nM] 
Amplicon 
size  
[bp] 
porcine 
target 
Forward primer 5’-ACA ACA TAA TCT GAA TCA ATG C 
-3’ 
600 83 
Reverse primer 5’-TTC GCC TAG TTG GTT TAG TAG -
3’ 
600 
Probe FAM- 5’-AGT ACA TAG TCT CCT CAT 
TAG CCT GAT C-3’ TAMRA 
250 
 
Table A2: Thermal cycling protocol used for the simplex dPCR reaction amplifying the 
porcine target 
Name Phase Time [s] Temperature [°C] Repeats 
UNG and 
Hot start 
UNG 120 50 
1 
Hot start 600 95 
PCR cycles 
 
Denaturation 15 95 
50 
Annealing 60 50 
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12. Annex B: Description of the ddPCR method 
The protocol described here was used to all the measurements at IRMM, as well as by all the 
laboratories participating in the characterisation study. The primers and probes were those, 
which were used for dPCR and were provided by the EURL-AP for qPCR. Volumes of 7.7 µL 
of the undiluted ERM-AD483a, ERM-AD483b, ERM-AD483c plasmid solutions were used in 
the ddPCR assay. A volume of 7.7 µL of the DNA sample was mixed with 14.3 µL of Pre-
sample mix solution and 20 µL of this mixture was loaded into a well of the droplet generator 
strip. 40 µL droplets were generated and loaded per well of a 96-well semi-skirted PCR plate. 
The 14.3 µL Pre-sample mix solution contains the primers and probes (1.1 µL each) for the 
porcine target at final concentrations as outlined in Table A1, together with 2x ddPCR 
supermix reagent (Cat. No.: 186-3010) (11 µL) from Bio-Rad (Bio-Rad Laboratories N.V., 
Temse, BE). The amplification was performed according to the specifications in Table A2. 
After amplification the droplets were read and the results analysed with the Quanta Soft V 
software using the appropriate threshold for each analysis. 
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13. Annex C: Sequence alignment of pIRMM-0104 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Seq1        GAGCGCCCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCATTAATGCAGCTGG 60 
Seq2        GAGCGCCCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCATTAATGCAGCTGG 60 
Seq3        GAGCGCCCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCATTAATGCAGCTGG 60 
            ************************************************************ 
 
Seq1        CACGACAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCAACGCAATTAATGTGAGTTAG 120 
Seq2        CACGACAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCAACGCAATTAATGTGAGTTAG 120 
Seq3        CACGACAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCAACGCAATTAATGTGAGTTAG 120 
            ************************************************************ 
 
Seq1        CTCACTCATTAGGCACCCCAGGCTTTACACTTTATGCTTCCGGCTCGTATGTTGTGTGGA 180 
Seq2        CTCACTCATTAGGCACCCCAGGCTTTACACTTTATGCTTCCGGCTCGTATGTTGTGTGGA 180 
Seq3        CTCACTCATTAGGCACCCCAGGCTTTACACTTTATGCTTCCGGCTCGTATGTTGTGTGGA 180 
            ************************************************************ 
 
Seq1        ATTGTGAGCGGATAACAATTTCACACAGGAAACAGCTATGACCATGATTACGAATTCGAG 240 
Seq2        ATTGTGAGCGGATAACAATTTCACACAGGAAACAGCTATGACCATGATTACGAATTCGAG 240 
Seq3        ATTGTGAGCGGATAACAATTTCACACAGGAAACAGCTATGACCATGATTACGAATTCGAG 240 
            ************************************************************ 
 
Seq1        CTCGGTACCCGGGGATCCTCTAGATGCATGCTCGAGCGGCCGCCAGTGTGATGGATATCT 300 
Seq2        CTCGGTACCCGGGGATCCTCTAGATGCATGCTCGAGCGGCCGCCAGTGTGATGGATATCT 300 
Seq3        CTCGGTACCCGGGGATCCTCTAGATGCATGCTCGAGCGGCCGCCAGTGTGATGGATATCT 300 
            ************************************************************ 
 
Seq1        GCAGAATTCGCCCTTACAACATAATCTGAATCAATGCAACAGTACATAGTCTCCTCATTA 360 
Seq2        GCAGAATTCGCCCTTACAACATAATCTGAATCAATGCAACAGTACATAGTCTCCTCATTA 360 
Seq3        GCAGAATTCGCCCTTACAACATAATCTGAATCAATGCAACAGTACATAGTCTCCTCATTA 360 
            ************************************************************ 
 
Seq1        GCCTGATCAGTCTATCCCTACTAAACCAACTAGGCGAAAAGGGCGAATTCCAGCACACTG 420 
Seq2        GCCTGATCAGTCTATCCCTACTAAACCAACTAGGCGAAAAGGGCGAATTCCAGCACACTG 420 
Seq3        GCCTGATCAGTCTATCCCTACTAAACCAACTAGGCGAAAAGGGCGAATTCCAGCACACTG 420 
            ************************************************************ 
 
Seq1        GCGGCCGTTACTAGTGGATCCGAGCTCGGTACCAAGCTTGGCACTGGCCGTCGTTTTACA 480 
Seq2        GCGGCCGTTACTAGTGGATCCGAGCTCGGTACCAAGCTTGGCACTGGCCGTCGTTTTACA 480 
Seq3        GCGGCCGTTACTAGTGGATCCGAGCTCGGTACCAAGCTTGGCACTGGCCGTCGTTTTACA 480 
            ************************************************************ 
 
Seq1        ACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCC 540 
Seq2        ACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCC 540 
Seq3        ACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCC 540 
            ************************************************************ 
 
Seq1        TTTCGCCAGCTGGCGTAATAGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCG 600 
Seq2        TTTCGCCAGCTGGCGTAATAGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCG 600 
Seq3        TTTCGCCAGCTGGCGTAATAGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCG 600 
            ************************************************************ 
 
Seq1        CAGCCTGAATGGCGAATGGCGCCTGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTAT 660 
Seq2        CAGCCTGAATGGCGAATGGCGCCTGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTAT 660 
Seq3        CAGCCTGAATGGCGAATGGCGCCTGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTAT 660 
            ************************************************************ 
 
Seq1        TTCACACCGCATATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCA 720 
Seq2        TTCACACCGCATATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCA 720 
Seq3        TTCACACCGCATATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCA 720 
            ************************************************************ 
 
Seq1        GCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATC 780 
Seq2        GCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATC 780 
Seq3        GCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATC 780 
            ************************************************************ 
 
Seq1        CGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTC 840 
Seq2        CGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTC 840 
Seq3        CGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTC 840 
            ************************************************************ 
 
Seq1        ATCACCGAAACGCGCGAGACGAAAGGGCCTCGTGATACGCCTATTTTTATAGGTTAATGT 900 
Seq2        ATCACCGAAACGCGCGAGACGAAAGGGCCTCGTGATACGCCTATTTTTATAGGTTAATGT 900 
Seq3        ATCACCGAAACGCGCGAGACGAAAGGGCCTCGTGATACGCCTATTTTTATAGGTTAATGT 900 
            ************************************************************ 
 
Seq1        CATGATAATAATGGTTTCTTAGACGTCAGGTGGCACTTTTCGGGGAAATGTGCGCGGAAC 960 
Seq2        CATGATAATAATGGTTTCTTAGACGTCAGGTGGCACTTTTCGGGGAAATGTGCGCGGAAC 960 
Seq3        CATGATAATAATGGTTTCTTAGACGTCAGGTGGCACTTTTCGGGGAAATGTGCGCGGAAC 960 
            ************************************************************ 
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Seq1        CCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGACAATAACC 1020 
Seq2        CCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGACAATAACC 1020 
Seq3        CCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGACAATAACC 1020 
            ************************************************************ 
 
Seq1        CTGATAAATGCTTCAATAATATTGAAAAAGGAAGAGTATGAGTATTCAACATTTCCGTGT 1080 
Seq2        CTGATAAATGCTTCAATAATATTGAAAAAGGAAGAGTATGAGTATTCAACATTTCCGTGT 1080 
Seq3        CTGATAAATGCTTCAATAATATTGAAAAAGGAAGAGTATGAGTATTCAACATTTCCGTGT 1080 
           ************************************************************ 
 
Seq1        CGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCT 1140 
Seq2        CGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCT 1140 
Seq3        CGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCT 1140 
            ************************************************************ 
 
Seq1        GGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGA 1200 
Seq2        GGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGA 1200 
Seq3        GGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGA 1200 
            ************************************************************ 
 
Seq1        TCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAG 1260 
Seq2        TCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAG 1260 
Seq3        TCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAG 1260 
            ************************************************************ 
Seq1        CACTTTTAAAGTTCTGCTATGTGGCGCGGTATTATCCCGTATTGACGCCGGGCAAGAGCA 1320 
Seq2        CACTTTTAAAGTTCTGCTATGTGGCGCGGTATTATCCCGTATTGACGCCGGGCAAGAGCA 1320 
Seq3        CACTTTTAAAGTTCTGCTATGTGGCGCGGTATTATCCCGTATTGACGCCGGGCAAGAGCA 1320 
            ************************************************************ 
Seq1        ACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGA 1380 
Seq2        ACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGA 1380 
Seq3        ACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGA 1380 
            ************************************************************ 
 
Seq1        AAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAG 1440 
Seq2        AAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAG 1440 
Seq3        AAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAG 1440 
           ************************************************************ 
 
Seq1        TGATAACACTGCGGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGC 1500 
Seq2        TGATAACACTGCGGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGC 1500 
Seq3        TGATAACACTGCGGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGC 1500 
           ************************************************************ 
 
Seq1        TTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAA 1560 
Seq2        TTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAA 1560 
Seq3        TTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAA 1560 
            ************************************************************ 
 
Seq1        TGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGTAGCAATGGCAACAACGTT 1620 
Seq2        TGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGTAGCAATGGCAACAACGTT 1620 
Seq3        TGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGTAGCAATGGCAACAACGTT 1620 
            ************************************************************ 
 
Seq1        GCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTG 1680 
Seq2        GCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTG 1680 
Seq3        GCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTG 1680 
            ************************************************************ 
Seq1        GATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTT 1740 
Seq2        GATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTT 1740 
Seq3        GATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTT 1740 
            ************************************************************ 
 
Seq1        TATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGG 1800 
Seq2        TATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGG 1800 
Seq3        TATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGG 1800 
            ************************************************************ 
 
Seq1        GCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTAT 1860 
Seq2        GCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTAT 1860 
Seq3        GCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTAT 1860 
           ************************************************************ 
 
Seq1        GGATGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAACT 1920 
Seq2        GGATGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAACT 1920 
Seq3        GGATGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAACT 1920 
            ************************************************************ 
 
Seq1        GTCAGACCAAGTTTACTCATATATACTTTAGATTGATTTAAAACTTCATTTTTAATTTAA 1980 
Seq2        GTCAGACCAAGTTTACTCATATATACTTTAGATTGATTTAAAACTTCATTTTTAATTTAA 1980 
Seq3        GTCAGACCAAGTTTACTCATATATACTTTAGATTGATTTAAAACTTCATTTTTAATTTAA 1980 
            ************************************************************ 
 
Seq1        AAGGATCTAGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGTGAGTT 2040 
Seq2        AAGGATCTAGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGTGAGTT 2040 
Seq3        AAGGATCTAGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGTGAGTT 2040 
            ************************************************************ 
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Seq1        TTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTT 2100 
Seq2        TTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTT 2100 
Seq3        TTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTT 2100 
            ************************************************************ 
 
Seq1        TTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTG 2160 
Seq2        TTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTG 2160 
Seq3        TTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTG 2160 
            ************************************************************ 
 
Seq1        TTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCA 2220 
Seq2        TTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCA 2220 
Seq3        TTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCA 2220 
            ************************************************************ 
 
Seq1        GATACCAAATACTGTTCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGT 2280 
Seq2        GATACCAAATACTGTTCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGT 2280 
Seq3        GATACCAAATACTGTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGT 2280 
            *************** ******************************************** 
 
Seq1        AGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGA 2340 
Seq2        AGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGA 2340 
Seq3        AGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGA 2340 
            ************************************************************ 
 
Seq1        TAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTC 2400 
Seq2        TAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTC 2400 
Seq3        TAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTC 2400 
            ************************************************************ 
 
Seq1        GGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACT 2460 
Seq2        GGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACT 2460 
Seq3        GGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACT 2460 
            ************************************************************ 
 
Seq1        GAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGA 2520 
Seq2        GAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGA 2520 
Seq3        GAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGA 2520 
            ************************************************************ 
 
Seq1        CAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGG 2580 
Seq2        CAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGG 2580 
Seq3        CAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGG 2580 
            ************************************************************ 
 
Seq1        AAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATT 2640 
Seq2        AAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATT 2640 
Seq3        AAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATT 2640 
            ************************************************************ 
 
Seq1        TTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTT 2700 
Seq2        TTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTT 2700 
Seq3        TTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTT 2700 
            ************************************************************ 
 
Seq1        ACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGA 2760 
Seq2        ACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGA 2760 
Seq3        ACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGA 2760 
            ************************************************************ 
 
Seq1        TTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAAC 2820 
Seq2        TTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAAC 2820 
Seq3        TTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAAC 2820 
            ************************************************************ 
 
Seq1        GACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAA 2857 
Seq2        GACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAA 2857 
Seq3        GACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAA 2857 
            ************************************* 
 
Legend: Seq1 is provided by Eurofins, Seq2 is provided by BaseClear, and Seq3 is an in silico 
sequence theoretical sequence. 
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14. Annex D: Raw data of the characterisation study 
Table A3: Raw data of the combined dPCR and ddPCR characterisation dataset of ERM-
AD483a 
 
 
Labs Mean s CI 95 % 
Samp#1 
dPCR 
Samp#2 
dPCR 
Samp#3 
dPCR 
Samp#4 
dPCR 
Samp#5 
dPCR 
Samp#6 
dPCR 
Samp#7 
dPCR 
L0-Coordinator 129.1271 14.3598 8.2911 156.32 140.84 136.98 148.85 138.23 122.59 114.68 
L1-Lab 1 128.1893 9.4479 5.455 119 128.67 125.22 125.02 148.03 123.3 122.04 
L2-Lab 2 128.577 7.7209 5.5232 139.77 136.27 133.92 136.36 119.47 121.18 120.33 
L3-Lab 3 115.404 11.5905 8.2913 128.67 98.45 98.66 114.79 113.91 124.78 105.81 
L4-Lab 4 138.8177 11.1423 6.7332 142.65 146.05 140.77 143.32 145.27 153.96 131.66 
L5-Lab 5 116.6314 15.1051 8.7214 106.24 98.95 99.41 93.77 103.94 136.13 127.46 
L6-Lab 6 125.173 8.7526 6.2613 118.29 136.44 130.02 125 120.42 112.74 122.67 
           
    
Samp#8 
dPCR 
Samp#9 
dPCR 
Samp#10 
dPCR 
Samp#11 
ddPCR 
Samp#12 
ddPCR 
Samp#13 
ddPCR 
Samp#14 
ddPCR 
L0-Coordinator 
   
119.73 108.2 109.01 132 120.91 132.13 127.31 
L1-Lab 1 
   
111.36 142.02 136.76 130.89 132.62 123.37 126.35 
L2-Lab 2 
   
123.61 131.3 123.56 - - - - 
L3-Lab 3 
   
127.54 127 114.43 - - - - 
L4-Lab 4 
   
- 152.66 147.94 130 121.7 126.66 121.99 
L5-Lab 5 
   
132.48 143.92 123.19 115.14 113.46 118.49 120.26 
L6-Lab 6 
   
137.7 132.87 115.58 - - - - 
  
Figure A1: Lab means and their standard deviation for the characterisation study of ERM-
AD483a, dPCR and ddPCR combined dataset 
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Table A4: Raw data of the combined dPCR and ddPCR characterisation dataset of ERM-
AD483b 
 
Labs Mean s CI 95 % 
Samp#1 
dPCR 
Samp#2 
dPCR 
Samp#3 
dPCR 
Samp#4 
dPCR 
Samp#5 
dPCR 
Samp#6 
dPCR 
Samp#7 
dPCR 
L0-Coordinator 32.4243 6.3837 3.6858 42.44 41.65 33.12 36.4 26.39 29.31 36 
L1-Lab 1 33.36 2.4927 1.4392 29.91 27.04 36.4 32.59 32.65 34.39 32.71 
L2-Lab 2 36.836 3.3478 2.3949 37.98 35.28 33.41 35.54 34.78 34.67 38.14 
L3-Lab 3 32.49 4.7171 3.3744 37.61 35.55 32.8 30.3 25.35 24.8 34.91 
L4-Lab 4 39.39 6.1875 3.5726 42.81 47.19 41.05 29.43 34.09 43.81 37.1 
L5-Lab 5 28.1871 3.7503 2.1654 31.68 29.79 21.69 26.75 29.77 24.61 29.87 
L6-Lab 6 33.793 8.0505 5.759 38.58 39.21 43.88 47.93 26.28 25.13 26.99 
           
    
Samp#8 
dPCR 
Samp#9 
dPCR 
Samp#10 
dPCR 
Samp#11 
ddPCR 
Samp#12 
ddPCR 
Samp#13 
ddPCR 
Samp#14 
ddPCR 
L0-Coordinator 
   
20.84 24.35 25.99 34.09 37.41 33.23 32.72 
L1-Lab 1 
   
33.31 35.86 33.39 34.25 36.22 33.61 34.71 
L2-Lab 2 
   
42.03 42.85 33.68 - - - - 
L3-Lab 3 
   
30.41 34.86 38.31 - - - - 
L4-Lab 4 
   
42.21 52.28 42.01 35.76 36.62 33.15 33.95 
L5-Lab 5 
   
23.76 21.71 30.09 31.58 32.4 29.79 31.13 
L6-Lab 6 
   
30.04 27.95 31.94 - - - - 
 
Figure A2: Lab means and their standard deviation for the characterisation study of ERM-
AD483b, dPCR and ddPCR combined dataset 
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Table A5: Raw data of the combined dPCR and ddPCR characterisation dataset of ERM-
AD483c 
 
 
Labs Mean s CI 95 % 
Samp#1 
dPCR 
Samp#2 
dPCR 
Samp#3 
dPCR 
Samp#4 
dPCR 
Samp#5 
dPCR 
Samp#6 
dPCR 
Samp#7 
dPCR 
L0-Coordinator 10.4 2.151 1.2419 12.47 8.67 12.07 11.37 14.75 12.48 10.45 
L1-Lab 1 10.0057 2.7696 1.5991 14.59 8.14 10.5 13.93 7.22 11.26 12.53 
L2-Lab 2 8.105 1.2782 0.9144 9.16 6.52 6.62 7.93 7.42 7.14 10.66 
L3-Lab 3 7.419 2.0761 1.4851 4.39 8.81 11.1 9.95 5.95 6.15 7.86 
L4-Lab 4 8.9229 2.0117 1.1615 9.47 9.41 6.05 14.03 9.93 11.49 8.14 
L5-Lab 5 7.0986 1.5364 0.8871 9.94 5.8 6.11 7.37 7.14 5.29 9.53 
L6-Lab 6 7.748 2.8047 2.0064 12.84 11.24 5.97 5.58 7.71 3.37 7.07 
           
    
Samp#8 
dPCR 
Samp#9 
dPCR 
Samp#10 
dPCR 
Samp#11 
ddPCR 
Samp#12 
ddPCR 
Samp#13 
ddPCR 
Samp#14 
ddPCR 
L0-Coordinator 
   
11.44 10.83 8.1 8.22 7.59 8.75 8.41 
L1-Lab 1 
   
8.08 13.75 8.58 8.54 5.97 7.75 9.24 
L2-Lab 2 
   
8.22 9.02 8.36 - - - - 
L3-Lab 3 
   
7.15 7.33 5.5 - - - - 
L4-Lab 4 
   
8.85 7.12 6.62 8.48 8.65 8.27 8.41 
L5-Lab 5 
   
4.93 5.41 8.35 7.68 6.57 8.07 7.19 
L6-Lab 6 
   
9.36 6.19 8.15 - - - - 
 
Figure A3: Lab means and their standard deviation for the characterisation study of ERM-
AD483c, dPCR and ddPCR combined dataset 
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